Cerebral vessel disease and inflammatory process

Brain and Nerve

Volumn 61, Issue 9, 2009, Pages 1061-1068

  Kitagawa, Kazuo ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Carotid atherosclerosis; High sensitivity C reactive protein (hs CRP); Inflammation; Interleukin; Silent cerebral infarction

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN;

ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL INJURY; BRAIN INFARCTION; CEREBRAL ARTERY DISEASE; DISEASE COURSE; DISEASE SEVERITY; HEART INFARCTION; HUMAN; INFLAMMATION; PROTEIN BLOOD LEVEL; REVIEW;

ANTI-INFLAMMATORY AGENTS; ARTERITIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CEREBRAL INFARCTION; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; STROKE;

EID: 70350066641     PISSN: 18816096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336: 973-979, 1997 (Pubitemid 27152782)
2. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, et al: Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack. The Framingham Study. Stroke 32: 2575-2579, 2001 (Pubitemid 33055308)
3. Ridker PM, Rifai N, Rose L, Buring J, Cook NR: Comaprison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347: 1557-1565, 2002 (Pubitemid 35315836)
4. Curb JD, Abbott RD, Rodriguez BL, Sakkinen P, Popper JS, et al: C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 107: 2016-2020, 2003 (Pubitemid 36506076)
5. Cesari M, Penninx BW, Newman AB, Kritchevsky SB, Nicklas BJ, et al: Inflammatory markers and onset of cardiovascular events. Results from the Health ABC Study. Circulation 108: 2317-2322, 2003
6. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, et al: High serum C-reactive protein level is not an independent predictor for stroke. The Rotterdam Study. Circulation 114: 1591-1598, 2006
7. Lorenz MW, Karbstein P, Markus HS, Sitzer M: High-sensitivity C-reactive protein is not associated with carotid intima-media progression. The Carotid Atherosclerosis Progression Study. Stroke 38: 1774-1779, 2007
8. Wakunaga Y, Kiyohara Y, Tanizaki Y, Kubo M, Ninomiya T, et al: C-reactive protein and risk of first-ever ischemic and hemorrhagic stroke in a general Japanese population. The Hisayama Study. Stroke 37: 27-32, 2006 (Pubitemid 43732043)
9. Kanai A, kawamura T, Umemura T, Nagashima M, Nakamura N, et al: Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 82: 157-164, 2008
10. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, et al: C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly. The Cardiovascular Health Study. Circulation 108: 166-170, 2003 (Pubitemid 36871298)
11. Cao JJ, Arnold AM, Manolio TA, Polak JF, Psaty BM, et al: Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: The Cardiovascular health Study. Circulation 116: 32-38, 2007
12. Ishikawa J, Tamura Y, Hoshide S, Eguchi K, Ishikawea S, et al: Low-grade inflammation is a risk factor for clinical stroke events in addition to silent cerebral infarcts in Japanese older hypertensives. The Jichi Medical School ABPM Study, wave 1. Stroke 38: 911-917, 2007
13. Woodward M, Lowe GD, Campbell DJ, Colman S, Rumley A, et al: Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 36: 2143-2147, 2005 (Pubitemid 41429235)
14. Welsh P, Lowe GD, Chalmers J, Campbell DJ, Rumley A, et al: Associations of proinflammatory cytokines with the risk of recurrent stroke. Stroke 39: 2226-2230, 2008
15. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359: 2195-2207, 2008
16. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, et al: Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA 292: 1845-1852, 2004
17. Redgrave JN, Lovett JK, Gallagher PJ, Rothwell PM: Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms. The Oxford plaque study. Circulation 113: 2320-2328, 2006
18. Krupinski J, Turu MM, Martinez-Gonzalez J, Carvajal A, Juan-Babot JO, et al: Endogenous expression of C-reactive protein is increased in active (ulcerated noncomplicated) human carotid artery plaques. Stroke 37: 1200-1204, 2006 (Pubitemid 43731862)
19. Hutter R, Valdiviezo C, Sauter BV, Savontaus M, Chereshnev I, et al: Caspase-3 and tissue factor expression in lipid-rich plaque macrophages. Evidence for apoptosis as link between inflammation and atherothromobosis. Circulation 109: 2001-2008, 2004
20. van der Meer IM, de Maat MP, Bots ML, Breteler MM, Meijer J, et al: Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis. The Rotterdam Study. Arterioscler Thromb Vasc Biol 22: 838-842, 2002 (Pubitemid 34517798)
21. Yamagami H, Kitagawa K, Hoshi T, Furukado S, Hougaku H, et al: Associations of serum IL-18 levels with carotid intima-media thickness. Aretrioscler Thromb Vasc Biol 25: 1458-1462, 2005 (Pubitemid 40923368)
22. Hashimoto H, Kitagawa K, Hougaku H, Shimizu Y, Sakaguchi M, et al: C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis. Circulation 104: 63-67, 2001 (Pubitemid 32623290)
23. Kondo K, Kitagawa K, Nagai Y, Yamagami H, Hashimoto H, et al: Associations of soluble intercellular adhesion molecule-1 with carotid atherosclerosis progression. Atherosclerosis 179: 155-160, 2005 (Pubitemid 40249798)
24. Sander D, Winbeck K, Klingelhöfer J, Etgen T, Conrad B: Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan Acute Respiratory) seropositivity. Circulation 103: 1390-1395, 2001 (Pubitemid 32220630)
25. Schillinger M, Exner M, Mlekusch W, Sabeti S, Amighi J, et al: Inflammation and Carotid Artery-Risk for Atherosclerosis Study (ICARAS). Circulation 111: 2203-2209, 2005 (Pubitemid 40632436)
26. Takiuchi S, rakugi H, Honda K, Masuyama T, Hirata N, et al: Quantitative ultrasonic tissue characterization can indetify high-risk atherosclerotic alteration in human carotid arteries. Circulation 102: 766-770, 2000
27. Gronholdt ML, Nordestgaard BG, Bentzon J, Wiebe BM, Zhou J, et al: Macrophages are associated with lipid-rich carotid artery plaque, echolucency on B-mode imaging, and elevated plasma lipid levels. J Vase Surg 35: 137-145, 2002 (Pubitemid 44725782)
28. Gronholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H: Ultrasonic echolucent carotid plaques predict future strokes. Circulation 104: 68-73, 2001 (Pubitemid 32623291)
29. Yamagami H, Kitagawa K, Nagai Y, Hougaku H, Sakaguchi M, et al: Higher levels of interleukin-6 are associated with lower echogenicity of carotid artery plaques. Stroke 35: 677-681, 2004 (Pubitemid 38280840)
30. Skjelland M, Michelsen AE, Krohg-Sørensen K, Tennøe B, Dahl A, et al: Plasma levels of granzyme B are increased in patients with lipid-rich carotid plaques as determined by echogenicity. Atherosclerosis 195: e142-146, 2007 (Pubitemid 350087972)
31. Kadoglou NP, Gerasimidis T, Golemati S, Kapelouzou A, Karayannacos PE, et al: The relationship between serum levels of vascular calcification inhibitors and carotid plaque vulnerability. J Vasc Surg 47: 55-62, 2008
32. Hangberg A, Skjelland M, Michelsen AE, Sagen EL, Krohg-Sørensen K, et al: Soluble CD36 in plasma is increased in patients with symptomatic atherosclerotic carotid plaques and is related to plaque instability. Stroke 39: 3092-3095, 2008
33. Uehara T, Tabuchi M, Mori E: Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol 12: 218-222, 2005 (Pubitemid 40278529)
34. Ogata J, Yutani C, Otsubo R, Yamanishi H, Naritomi H, et al: Heart and vessel pathology underlying brain infarction in 142 stroke patients. Ann Neurol 63: 770-781, 2008 (Pubitemid 351945536)
35. Arenillas JF, Alvarez-Sabín J: Basic mechanisms in intracranial large-artery atherosclerosis: advances and challenges. Cerebrovasc Dis 20(Suppl 2): 75-83, 2005
36. Arenillas JF, Alvarez-Sabín J, Molina CA, Chacón P, Fernandez-Cadenas I, et al: Progression of symptomatic intracranial large artery atherosclerosis is associated with a proinflammatory state and impaired fibrinolysis. Stroke 39: 1456-1463, 2008
37. Fassbender K, Bertsch T, Mielke O, Mühlhauser F, Hennerici M: Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 30: 1647-1650, 1999
38. Bang OY, Saver JL, Ovbiagele B, Choi YJ, Yoon SR, et al: Adiponectin levels in patients with intracranial atherosclerosis. Neurology 68: 1931-1937, 2007
39. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, et al: Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis 197: 326-332, 2008 (Pubitemid 351273254)
40. Takahashi W, Ohnuki T, Ohnuki Y, Kawada S, Takagi S: The role of high-sensitivity C-reactive protein in asymptomatic intra- and extracranial large artery diseases. Cerebrovasc Dis 26: 549-555, 2008
41. Akiguchi T, Tomimoto H, Suenaga T, Wakita H, Budka H: Alterations in glia and axons in the brain of Binswanger's disease patients. Stroke 28: 1423-1429, 1997 (Pubitemid 27300682)
42. Hassan A, Hunt BJ, O'Sullivan M, Parmer K, Bamford JM, et al: Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis. Brain 126(Pt 2): 424-432, 2003 (Pubitemid 36172746)
43. Shibata H, Nabika T, Moriyama H, Masuda J, Kobayashi S: Correlation of NO metabolites and 8-iso-prostaglandin F2a with periventricular hyperintensity severity. Arterioscler Thromb Vasc Biol 24: 1659-1663, 2004 (Pubitemid 39180891)
44. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, et al: Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 36: 768-772, 2005 (Pubitemid 40490622)
45. van Dijk EJ, Prins ND, Vermeer SE, Vrooman HA, Hofman A, et al: C-reactive protein and cerebral small-vessel disease. The Rotterdam Scan Study. Circulation 112: 900-905, 2005
46. Fornage M, Chiang YA, O'Meara ES, Psaty BM, Reiner AP, et al: Biomarkers of Inflammation and MRI-Defined Small Vessel Disease of the Brain. The Cardiovascular Health Study. Stroke 39: 1952-1959, 2008
47. Wada M, Nagasawa H, Kurita K, Koyama S, Arakawa S, et al: Cerebral small vessel disease and C-reactive protein: results of a cross-sectional study in community-based Japanese elderly. J Neurol Sci 264: 43-49, 2008 (Pubitemid 350184068)
48. Kawamura T, Umemura T, kanai A, nagashima M, Nakamura N, et al: Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patinets with type 2 diabetes mellitus. Metabolism 55: 461-466, 2006
49. Markus HS, Hunt B, Palmer K, Enzinger C, Schmidt H, et al: Markers of endothelial and hemostatic activation and progression of cerebral white matter hyper-intensities. Longitudinal results of the Austrian Stroke Prevention Study. Stroke 36: 1410-1414, 2005